Collegium Pharmaceutical COLL Ratios (2014-2026)

NASDAQ COLL
$22.23 -0.40 (-1.77%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Collegium Pharmaceutical Quarterly Ratios

Periods 47 quarters
Latest Jun 2026

Collegium Pharmaceutical reported a gross margin of 55.18% and a net margin of -7.53% for the quarter ended Jun 2026. These financial ratios cover 47 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
58.49%-4.87%57.90%42.38%46.33%38.41%53.47%54.47%58.75%63.19%63.11%62.51%60.76%54.02%54.75%57.65%61.70%62.49%60.59%55.18%
EBT Margin
11.46%-142.08%-18.92%-5.38%1.13%-6.01%-12.13%13.13%21.05%31.19%25.27%20.03%9.78%9.49%1.76%9.06%20.75%14.13%9.68%-6.77%
EBIT Margin
17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%29.57%15.97%1.85%
EBITDA Margin
39.82%-61.78%11.49%39.88%46.06%42.32%43.46%54.59%60.10%64.88%58.59%57.09%48.08%52.01%44.02%48.78%56.65%57.02%44.87%34.25%
Operating Margin
17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%29.57%15.97%1.85%
Net Margin
10.21%-91.49%-15.60%-4.20%0.36%-5.55%-12.04%9.60%15.09%21.33%19.12%13.50%5.86%6.89%1.36%6.37%15.05%8.26%7.49%-7.53%
FCF Margin
21.53%130.41%-30.36%32.37%33.58%50.44%18.99%73.53%54.10%48.87%42.35%46.21%-5.80%46.21%30.72%38.50%37.38%59.56%29.37%35.44%
Efficiency
Inventory AverageInventory Avg.
18.48M17.38M48.77M78.96M71.21M55.58M39.70M29.46M30.08M33.23M31.80M29.57M32.95M36.80M36.39M37.68M38.10M39.48M41.83M78.00M
Assets AverageAssets Avg.
727.77M716.94M969.11M1,245.86M1,223.26M1,187.54M1,194.21M1,214.11M1,195.74M1,160.44M1,128.78M1,083.82M1,344.27M1,649.37M1,647.49M1,612.01M1,599.98M1,632.08M1,654.39M1,893.87M
Equity AverageEquity Avg.
252.08M227.01M199.50M196.84M197.40M196.02M187.29M190.27M189.84M187.15M208.80M219.38M225.43M231.56M231.64M233.32M253.51M288.24M307.05M312.17M
Invested CapitalInvested Cap.
373.06M312.95M824.47M803.30M780.12M754.92M716.84M694.04M628.09M600.48M582.86M532.76M864.58M844.16M834.72M817.44M844.97M872.79M876.77M1,164.73M
Asset Utilization RatioAsset Util.
0.450.390.280.250.300.390.440.440.460.490.500.530.450.380.400.440.470.480.480.43
Leverage & Solvency
Interest Coverage RatioInterest Cover
2.77-7.17-1.720.631.070.571.151.632.173.202.853.051.891.681.041.722.853.151.950.19
Debt Ratio
0.160.160.500.490.490.480.440.410.380.350.320.300.390.370.370.370.350.340.340.40
Times Interest Earned
2.77-7.17-1.720.631.070.571.151.632.173.202.853.051.891.681.041.722.853.151.950.19
Valuation
Price to EarningsP/E
6.648.7916.1481.9620.3713.6110.4214.0613.0221.8525.7218.9223.3514.3024.55
Price to SalesP/S
2.112.272.531.931.501.691.581.391.351.732.241.802.081.431.441.321.461.881.351.46
Price to BookP/B
2.743.103.523.062.744.034.623.724.135.025.714.815.323.944.094.024.024.873.433.77
Enterprise Value
493.65M442.26M583.98M481.71M406.95M611.61M560.12M420.61M434.37M670.37M951.59M769.06M1,125.41M738.00M761.36M710.76M819.85M1,081.38M649.95M1,046.97M
EV to EBIT
7.4025.0918.368.244.553.714.024.963.785.824.345.365.485.226.023.446.65
EV to EBITDA
3.645.1110.116.564.053.552.481.681.592.122.812.223.292.182.292.082.142.671.572.68
Market Capitalization
686.90M628.68M690.68M604.43M541.08M785.30M829.60M746.08M738.93M980.91M1,269.64M1,040.69M1,245.37M900.76M959.13M932.91M1,105.71M1,468.06M1,071.70M1,176.44M
Price to FCFP/FCF
7.896.1912.328.995.826.404.733.172.773.584.123.786.474.434.884.623.824.483.253.58
EV to FCF
5.674.3510.427.174.384.993.191.791.632.443.092.795.853.633.873.522.833.301.973.19
EV to CFO
5.494.2710.137.024.324.923.161.781.622.443.082.785.813.603.843.492.823.281.963.17
Return Ratios
Return on Sales [ROS]ROS
17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%29.57%15.97%1.85%
Return on Capital Employed [ROCE]ROCE
14.55%4.03%-2.28%-2.27%-1.55%4.42%8.70%11.87%16.01%23.77%28.11%32.74%21.87%14.90%12.24%11.31%13.69%15.07%15.49%12.07%
Return on Invested Capital [ROIC]ROIC
17.56%0.00%0.00%-1.56%-1.13%3.76%8.87%13.11%7.52%17.28%23.28%25.83%19.17%13.96%11.42%10.75%13.65%14.20%14.95%9.51%
Return on Assets [ROA]ROA
14.22%9.98%4.41%-2.83%-3.50%-2.11%-2.46%-0.92%0.75%4.15%8.27%9.22%6.59%4.19%2.66%2.25%3.65%3.85%4.53%2.53%
Return on Equity [ROE]ROE
41.06%31.50%21.45%-17.91%-21.70%-12.75%-15.68%-5.87%4.75%25.73%44.68%45.54%39.30%29.88%18.95%15.55%23.05%21.81%24.41%15.35%

Collegium Pharmaceutical Ratios API

Pull Collegium Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=COLL&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY